C12N 2760/16033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/16033 (Use of viral protein as therapeutic agent other than vaccine) appears on 7 US grants and 15 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 15
- Assignees
- 7
- Inventors
- 23
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 2 | 2 |
| 2021 | 0 | 4 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 3 | 1 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Influenza virus hemagglutinin mutants30 Sep 2025US 12,428,661 B2Aramis Biotechnologies Inc.
- Influenza virus hemagglutinin mutants12 Nov 2024US 12,139,511 B2Aramis Biotechnologies Inc.
- Influenza virus hemagglutinin mutants1 Oct 2024US 12,104,196 B2Aramis Biotechnologies Inc.
- Anti-abeta therapeutic vaccines11 Jun 2024US 12,005,102 B2AC Immune SA
- Anti-abeta therapeutic vaccines10 Nov 2020US 10,828,351 B2AC Immune SA
- Influenza virus hemagglutinin mutants17 Apr 2025US 2025/0122549 A1Aramis Biotechnologies Inc.
- Anti-Abeta Therapeutic Vaccines24 Oct 2024US 2024/0350598 A1AC Immune SA
- Destroying Cancer Cells While Maintaining Healthy Cell Integrity30 Nov 2023US 2023/0381294 A1
- Influenza virus hemagglutinin mutants2 Dec 2021US 2021/0371472 A1Medicago Inc.
- Influenza virus hemagglutiniin mutants4 Nov 2021US 2021/0340184 A1Medicago Inc.
Most cited
By later US patents